Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers

Vaccine

Volumn 22, Issue 17-18, 2004, Pages 2273-2277

  Metzger, W G ^a   Mansouri, E ^b   Kronawitter, M ^a   Diescher, S ^a   Soerensen, M ^a   Hurwitz, R ^a   Bumann, D ^a   Aebischer, T ^a   Von Specht, B U ^b   Meyer, T F ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cellular immune responses; Clinical trial; Oral vaccination

Indexed keywords

RECOMBINANT SALMONELLA ENTERICA SEROVAR TYPHI TY21A VACCINE; RECOMBINANT VACCINE; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNIZATION; IMMUNOGENICITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALMONELLA ENTERICA;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MALE; PLASMIDS; RECOMBINANT PROTEINS; SALMONELLA TYPHI; SALMONELLA VACCINES; UREASE; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 2442498417     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.11.020     Document Type: Article

References (25)

1. Marshall B.J., Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1(8390):1984;1311-1315
2. Blaser M.J., Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia (review [42]). J. Clin. Invest. 94(1):1994;4-8
3. Logan R.P. Helicobacter pylori and gastric cancer. Lancet. 344(8929):1994;1078-1079
4. Kreiss C., Buclin T., Cosma M., Corthesy-Theulaz I., Michetti P. Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection [letter]. Lancet. 347(9015):1996;1630-1631
5. Michetti P., Kreiss C., Kotloff K.L., et al. Oral immunization with urease and Eschericia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology. 116:1999;804-812
6. DiPetrillo M.D., Tibbetts T., Kleanthous H., Killeen K.P., Hohmann E.L. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. Vaccine. 18(5-6):1999;449-459
7. Angelakopoulos H., Hohmann E.L. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect Immun. 68(4):2000;2135-2141
8. Ermak T.H., Giannasca P.J., Nichols R., et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp. Med. 188(12):1998;2277-2288
9. Blanchard T.G., Czinn S.J., Redline R.W., Sigmund N., Harriman G., Nedrud J.G. Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice. Cell Immunol. 191(1):1999;74-80
10. Sutton P., Wilson J., Kosaka T., Wolowczuk I., Lee A. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies. Immunol. Cell Biol. 78(1):2000;28-30
11. Aebischer T., Lucas B., Koesling J., Bumann D., Meyer T.F. How CD4(+) T cells may eliminate extracellular gastric Helicobacter? J. Biotechnol. 83(1-2):2000;77-84
12. Akhiani A.A., Pappo J., Kabok Z., et al. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J. Immunol. 169(12):2002;6977-6984
13. Garhart C.A., Nedrud J.G., Heinzel F.P., Sigmund N.E., Czinn S.J. Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4. Infect. Immun. 71(6):2003;3628-3633
14. Gomez-Duarte O.G., Lucas B., Yan Z.X., Panthel K., Haas R., Meyer T.F. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. Vaccine. 16(5):1998;460-471
15. Koesling J., Lucas B., Develioglou L., Aebischer T., Meyer T.F. Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy. Vaccine. 20(3-4):2001;413-420
16. Bumann D., Metzger W.G., Mansouri E., et al. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine. 20(5-6):2001;845-852
17. Dearlove C.E., Forrest B.D., van den Bosch L., La Brooy J.T. The antibody response to an oral Ty21a-based typhoid-cholera hybrid is unaffected by prior oral vaccination with Ty21a [letter]. J. Infect. Dis. 165(1):1992;182-183
18. Waldrop S.L., Pitcher C.J., Peterson D.M., Maino V.C., Picker L.J. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J. Clin. Invest. 99(7):1997;1739-1750
19. Bao J.X., Clements J.D. Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers. Infect Immun. 59(10):1991;3841-3845
20. Whittle B.L., Verma N.K. The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience. Vaccine. 15(16):1997;1737-1740
21. Attridge S.R., Davies R., LaBrooy J.T. Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain. Vaccine. 15(2):1997;155-162
22. Roberts M., Bacon A., Li J., Chatfield S. Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C. Infect Immun. 67(8):1999;3810-3815
23. Vindurampulle C.J., Attridge S.R. Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines. Infect. Immun. 71(1):2003;287-297
24. Viret J.F., Favre D., Wegmuller B., et al. Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria. Infect Immun. 67(7):1999;3680-3685
25. Kantele A., Makela P.H. Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine. Vaccine. 9(6):1991;423-427